To find out the effect of Kalyanakshara with Vizhalveradi kashaya in Tamoxifen induced Endometrial hyperplasia in breast cancer

Effect of Kalyana kshara with Vilalveradi kashaya in selective estrogen receptor modulator (Tamoxifen) induced endometrial hyperplasia in breast cancer A single group pre test -post test trial. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073520

Enrollment

Registered

2024-09-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N850- Endometrial hyperplasia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Participants with breast cancer taking Tamoxifen for more than 6 months, diagnosed with endometrial hyperplasia. Age group of 25-65 years. Participants with written consent.

Exclusion criteria

Exclusion criteria: Uncontrolled DM (HbA1c >6.5) HTN ( BP >150/100mmHg) CVD

Design outcomes

Primary

Measure	Time frame
Reduction of endometrial thickness assessed through ultra sound imagingTimepoint: 0th and 61st day	—

Secondary

Measure	Time frame
quality of life assessment using QLQ C-30 and QLQ BR-45Timepoint: 0th 31st and 61st day	—

Countries

India

Contacts

Public ContactDR REJANI H

VPSV Ayurveda college Kottakkal

drrejaniharidas@gmail.com9447270227

Outcome results